Retina

49-64 of 340

Presbyopia-Correcting Drops: Counseling Patients on Dosing, Side Effects, and the Importance of Retinal Exams

Presbyopia-Correcting Drops: Counseling Patients on Dosing, Side Effects, and the Importance of Retinal Exams
CME/CE

Presbyopia-Correcting Drops: Counseling Patients on Dosing, Side Effects, and the Importance of Retinal Exams
Christina Y. Weng, MD, MBA, FASRS; Jaclyn Garlich, OD, FAAO
0.25 credits
- Christina Y. Weng, MD, MBA, FASRS
- Jaclyn Garlich, OD, FAAO
0.25 credits
Achieving Durable Outcomes in Treatment-Naïve nAMD
Achieving Durable Outcomes in Treatment-Naïve nAMD
CME/CE
Achieving Durable Outcomes in Treatment-Naïve nAMD
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
- Sunir J. Garg, MD, FACS, FASRS
- Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Presbyopia-Correcting Drops: The Importance of Patient Selection
Presbyopia-Correcting Drops: The Importance of Patient Selection
CME/CE
Presbyopia-Correcting Drops: The Importance of Patient Selection
Christina Y. Weng, MD, MBA, FASRS; Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
- Christina Y. Weng, MD, MBA, FASRS
- Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
Retina Specialist Perspectives
Retina Specialist Perspectives
CME/CE
Retina Specialist Perspectives
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
- Sunir J. Garg, MD, FACS, FASRS
- Charles C. Wykoff, MD, PhD, FACS
0.25 credits
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
CME/CE Broadcast Replay
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
Sunir J. Garg, MD, FACS, FASRS; John W. Kitchens, MD
1.00 credit
- Sunir J. Garg, MD, FACS, FASRS
- John W. Kitchens, MD
- Sara LeMay, OD
- Charles C. Wykoff, MD, PhD, FACS
1.00 credit
Macular Leakage: Indicator of Vascular Stability
Macular Leakage: Indicator of Vascular Stability
MinuteCE®
Macular Leakage: Indicator of Vascular Stability
Justis P. Ehlers, MD, FASRS; Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
Predicting Durability: Where Are We Now?
Predicting Durability: Where Are We Now?
MinuteCE®
Predicting Durability: Where Are We Now?
Justis P. Ehlers, MD, FASRS; Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
Beyond Durability - What Biomarkers Reveal About Disease Control
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®
Beyond Durability - What Biomarkers Reveal About Disease Control
Justis P. Ehlers, MD, FASRS; Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
Fluid Dynamics Demystified
Fluid Dynamics Demystified
MinuteCE®
Fluid Dynamics Demystified
Roger A. Goldberg, MD, MBA; Ehsan Rahimy, MD
1.00 program credit
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credit
MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
Justis P. Ehlers, MD, FASRS; Roger A. Goldberg, MD, MBA
1.00 credit 10 episodes
- Justis P. Ehlers, MD, FASRS
- Roger A. Goldberg, MD, MBA
- Jennifer, I. Lim, MD, FASRS, FARVO
- Ehsan Rahimy, MD
1.00 credit 10 episodes
Early Fluid Resolution – A Key to Long-Term Success
Early Fluid Resolution – A Key to Long-Term Success
MinuteCE®
Early Fluid Resolution – A Key to Long-Term Success
Roger A. Goldberg, MD, MBA; Ehsan Rahimy, MD
1.00 program credit
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credit
Real-World Adaptation of Trial Protocols
Real-World Adaptation of Trial Protocols
MinuteCE®
Real-World Adaptation of Trial Protocols
Roger A. Goldberg, MD, MBA; Ehsan Rahimy, MD
1.00 program credit
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credit
Signs of Progress: PED as a Predictor of Disease and Outcomes
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®
Signs of Progress: PED as a Predictor of Disease and Outcomes
Justis P. Ehlers, MD, FASRS; Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
The Durability Dilemma
The Durability Dilemma
MinuteCE®
The Durability Dilemma
Roger A. Goldberg, MD, MBA; Ehsan Rahimy, MD
1.00 program credit
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credit
Fluid Foundations: How Location Impacts Outcomes in nAMD
Fluid Foundations: How Location Impacts Outcomes in nAMD
MinuteCE®
Fluid Foundations: How Location Impacts Outcomes in nAMD
Roger A. Goldberg, MD, MBA; Ehsan Rahimy, MD
1.00 program credit
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credit
Second-Generation Biomarkers for Treatment Outcomes
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®
Second-Generation Biomarkers for Treatment Outcomes
Justis P. Ehlers, MD, FASRS; Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credit

4/9